To further demonstrate that Src overexpression requires NRF2 to inhibit ferroptosis in GBM cells, we compared sensitivity with erastin in SrcWT and SrcKD cells transiently overexpressing NRF2WT, or an empty vector as a control. The gene discussed is NFE2L2; the disease is glioblastoma.